Designed for academic researchers, biotech, insurance, and regulatory governance.
Real World Data provides the evidence needed to inform efficient psychedelic studies. Aggregate, derivative population data covering mental health treatments and outcomes are presented in an analytics dashboard, allowing you to segment data in real-time.
Harness the power of real world data.
Real world data provides evidence for clinical efficacy and generate signals to inform further controlled study. Real world practices can directly instruct clinical pathway design, reducing current trial-and-error approaches, and accelerating safe care delivery.
Decrease costs and time.
Real world psychedelic data provides the opportunity to observe treatment practices and outcomes at a dramatically reduced cost in time and money vs running controlled studies.
Increase access to qualified study participants.
By empowering individuals with insight and clarity in their own healing journey, we can activate a global ‘army’ of qualified citizen scientists who are willing to participate in psychedelic studies.
Build your research protocol easily using Maya’s Protocol elements ranging from individual therapeutic interventions to content elements for education during preparation and integration stages.
View results and calculate cohort performance in real-time through Maya’s integrated Insights Dashboard.
Customize and manage all communications with participant through the Maya Companion App.
The Maya Insights dashboard offers an unparalleled opportunity for real time analysis and preliminary investigation. All data is structured in a consistent and universal 'common data model', allowing for retroactive meta analysis and cross-study comparison.
Analysis-ready datasets covering diverse populations
(Coming soon)
Enhanced compliance vs general registries
(Coming soon)
Faster, cheaper participant recruitment
(Coming soon)
Retained data ownership & embargoed publishing rights
(Coming soon)
Unified data modeling & analysis across recruitment sites
(Coming soon)
HIPAA-compliant & IRB-approved methodologies
(Coming soon)
Enhanced participant experience & outcomes
(Coming soon)
Co-opted press & publicity for studies
(Coming soon)
Significantly larger datasets vs controlled study
(Coming soon)
Improved compliance
(Coming soon)
Improved compliance
(Coming soon)
The following materials provide information about how real world evidence is an efficient approach to conducting biomedical research.
Read our last article
Posted on
March 29, 2023
Listen our last podcast
Posted on
December 15, 2022